🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

George Soros’s BLFS Holdings & Trades

First Buy
Q3 2026
Duration Held
1 Quarters
Largest Add
Q3 2026
+671,025 Shares
Current Position
671,025 Shares
$26.07 M Value

George Soros's BLFS Position Overview

George Soros (via Soros Fund Management LLC) currently holds 671,025 shares of BioLife Solutions, Inc. (BLFS) worth $26.07 M, representing 0.31% of the portfolio. First purchased in 2026-Q3, this recently established position has been held for 1 quarters.

Based on recent 13F filings, George Soros has initiated a new position in BLFS, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.

Analysis based on 13F filings available since 2013 Q2

George Soros's BioLife Solutions (BLFS) Holding Value Over Time

Track share changes against reported price movement

Quarterly BioLife Solutions (BLFS) Trades by George Soros

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +671,025 New Buy 671,025 $38.85

George Soros's BioLife Solutions Investment FAQs

George Soros first purchased BioLife Solutions, Inc. (BLFS) in Q3 2026, acquiring 671,025 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

George Soros has held BioLife Solutions, Inc. (BLFS) for 1 quarters since Q3 2026.

George Soros's largest addition to BioLife Solutions, Inc. (BLFS) was in Q3 2026, adding 671,025 shares worth $26.07 M.

According to the latest 13F filing for Q3 2026, George Soros's firm, Soros Fund Management LLC, owns 671,025 shares of BioLife Solutions, Inc. (BLFS), valued at approximately $26.07 M.

As of the Q3 2026 filing, BioLife Solutions, Inc. (BLFS) represents approximately 0.31% of George Soros's publicly disclosed stock portfolio, making it one of their key holdings.

George Soros's peak holding in BioLife Solutions, Inc. (BLFS) was 671,025 shares, as reported at the end of Q3 2026.